Wasatch Advisors’s China Biologic Products Holdings, Inc. CBPO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2019
Q3
Sell
-119,147
Closed -$11.4M 253
2019
Q2
$11.4M Sell
119,147
-26,315
-18% -$2.48M 0.11% 126
2019
Q1
$13.3M Sell
145,462
-31,903
-18% -$2.61M 0.14% 110
2018
Q4
$13.5M Sell
177,365
-100,550
-36% -$7.4M 0.18% 94
2018
Q3
$22.2M Sell
277,915
-7,944
-3% -$740K 0.25% 82
2018
Q2
$28.4M Sell
285,859
-6,357
-2% -$549K 0.34% 75
2018
Q1
$23.7M Buy
292,216
+63,843
+28% +$5.16M 0.31% 74
2017
Q4
$18M Buy
228,373
+90,891
+66% +$7.56M 0.24% 84
2017
Q3
$12.7M Sell
137,482
-54,114
-28% -$5.2M 0.17% 101
2017
Q2
$21.7M Buy
191,596
+51,846
+37% +$5.79M 0.3% 76
2017
Q1
$14M Sell
139,750
-31,530
-18% -$3.37M 0.21% 92
2016
Q4
$18.4M Sell
171,280
-17,039
-9% -$1.99M 0.28% 79
2016
Q3
$23.4M Sell
188,319
-1,644
-0.9% -$194K 0.35% 77
2016
Q2
$20.2M Sell
189,963
-1,082
-0.6% -$126K 0.31% 84
2016
Q1
$21.8M Sell
191,045
-105,528
-36% -$12.4M 0.33% 84
2015
Q4
$42.3M Sell
296,573
-28,127
-9% -$3.25M 0.58% 57
2015
Q3
$29.2M Buy
+324,700
New +$34.3M 0.39% 83

Other funds holding CBPO

Wasatch Advisors's CBPO Position: Q3 2019 in Review

Wasatch Advisors sold out of China Biologic Products Holdings, Inc. (CBPO) in Q3 2019, closing a stake of 119,147 shares — an estimated $11.4M sold.

Wasatch Advisors first reported a position in CBPO in Q3 2015 and held it in 16 quarters. The position peaked at $42.3M in Q4 2015. 88 funds tracked by Wall St. Rank hold CBPO as of Q3 2019.

  • Wasatch Advisors reported no remaining China Biologic Products Holdings, Inc. position as of Q3 2019 after selling out during the quarter.
  • Wasatch Advisors sold 119,147 China Biologic Products Holdings, Inc. shares in Q3 2019, an estimated $11.4M.
  • Wasatch Advisors first reported a position in China Biologic Products Holdings, Inc. in Q3 2015 and held it in 16 quarters.
  • Wasatch Advisors's China Biologic Products Holdings, Inc. position peaked at $42.3M in Q4 2015.
  • 88 funds tracked by Wall St. Rank held China Biologic Products Holdings, Inc. as of Q3 2019.

Based on Wasatch Advisors's 13F filing for Q3 2019, filed 14 Nov 2019.